NCT02571049View on ClinicalTrials.gov

Pilot Study of Two Different Strengths of DFN-11 Injection for Rapidly Escalating Migraine

PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

April 30, 2016

Study Completion Date

May 31, 2016

Conditions
Rapidly Escalating Migraine
Interventions
DRUG

DFN-11

Sumatriptan 3 mg versus 6 mg

Trial Locations (1)

65807

Clinvest, Springfield

Sponsors
All Listed Sponsors
lead

Dr. Reddy's Laboratories Limited

INDUSTRY